Skip to content

Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris

Efficacy of Lesser Known Homoeopathic Medicines in Acne Vulgaris - Azadirachta Indica

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01321645
Enrollment
31
Registered
2011-03-23
Start date
2011-03-31
Completion date
2012-06-30
Last updated
2012-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris

Keywords

Acne Vulgaris, Homoeopathy, Homeopathy, Azadirachta Indica

Brief summary

Acne is one of the most common skin problems in teenagers and adolescents. There are many lesser known homoeopathic medicines which have been mentioned in the literature for treatment of acne but their potential has not been properly assessed /documented and therefore these medicines don't form a part of many prescriptions. As a part of this study,efficacy of Azadirachta Indica will be studied in the treatment of Acne vulgaris

Interventions

To start with subjects will be prescribed Azadirachta Indica in 6 potency to be taken in form of pills 4 times a day for seven days. Dosage and frequency will be changed, if required, based on the condition of subject and their response according to homoeopathic principles.

Sponsors

Department of Indian Systems of Medicine and Homeopathy
CollaboratorOTHER
Miglani, Anjali
Lead SponsorINDIV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Males and females between 12 to 25 years of age * Presence of inflammatory and non-inflammatory lesions * Able to follow-up according to protocol * Patients not taking any medication for treatment of Acne in preceding one month.

Exclusion criteria

* Acne Conglobata * Pregnant or Breast feeding females or females having intention of becoming pregnant * Significant systemic disease * Any drug/ alcohol addiction * History of chronic diseases treated with medications in the preceding month which might affect acne condition and treatment outcome

Design outcomes

Primary

MeasureTime frame
percent change in acne lesion counts from the Baseline6 months

Secondary

MeasureTime frameDescription
change in quality of life of subjects from baseline6 monthsChange in Quality of life will be assessed based on Quality of Life Questionnaire to be filled by subjects at the start of Treatment and at the end of time frame.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026